drugset / Trial / NCT02369939

Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy

NCT02369939

RandomizedParallel-groupOpen-labelTreatment

Summary

Randomized study to investigate the efficacy of deep regional hyperthermia in patients with anal carcinoma treated by standard radiochemotherapy with MMC and 5-FU.

Timeline

Start
2014-12
Primary completion
2017-12
Completion
2021-04

Drugs

EvaluationDrugModalityDoseRoute
Background Mitomycin C Other / unclassified 10 mg/m2
Background fluorouracil Small molecule 1000 mg/m2

Indications